Shuko Saku

Early phase II study of mixed 19‐peptide vaccine monotherapy for refractory triple‐negative breast cancer

Y. Akagi, S. Shichijo, K. Itoh, 2020, Cancer science.

Diagnosis and the Management of Flat Epithelial Atypia (FEA)

M. Yamaguchi, R. Yamaguchi, H. Otsuka, 2015 .

Plasma level of prostate related-antigen peptide-reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccines

Y. Akagi, S. Shichijo, K. Itoh, 2021, Experimental and therapeutic medicine.

Feasibility study of multiple HLA-class IA restricted peptide vaccines (KRM-19) for metastatic triple negative breast cancer (TNBC).

Y. Akagi, S. Shichijo, K. Itoh, 2017 .

A case of retrograde intussusception at Roux-en-Y anastomosis 10 years after total gastrectomy: review of the literature

Y. Akagi, K. Okuda, K. Kiyomatsu, 2016, Surgical Case Reports.

Predictive factors of the tumor immunological microenvironment for long‐term follow‐up in early stage breast cancer

Y. Akagi, K. Itoh, U. Toh, 2017, Cancer science.